Journal
STEM CELLS
Volume 32, Issue 5, Pages 1059-1066Publisher
WILEY
DOI: 10.1002/stem.1629
Keywords
Cellular therapy; Angiogenesis; Vascular Progenitor cells; Endothelial differentiation; Endothelial cell; Embryonic stem cells; Differentiation; miRNA
Categories
Funding
- BHF Fellowship
- BHF Centre of Vascular Regenerative Medicine
- National Institute for Health Research Bristol Cardiovascular Biomedical Research Unit
- National Institute for Health Research [NF-SI-0611-10022] Funding Source: researchfish
Ask authors/readers for more resources
MicroRNAs (miRs) are highly conserved, short noncoding RNA molecules that negatively regulate messenger RNA (mRNA) stability and/or translational efficiency. Since a given miR can control the expression of many mRNAs, their importance in governing gene expression in specific cell types including vascular cells and their progenitor cells has become increasingly clear. Understanding how the expression of miRs themselves is regulated and how miRs exert their influence on post-transcriptional gene control provides novel opportunities to dissect gene regulatory networks in clinically relevant cell types. A multitude of miRs have been identified with key roles in vascular development, homeostasis, function, disease, and regeneration. In this review, we will describe the impact of miRs on angiogenesis and their capacity to modulate the behavior of stem and progenitor cells which may be utilitarian for promoting vascular growth in ischemic tissue. Moreover, we summarize these strategies available for modulating miR expression and function and future therapeutic applications. Stem Cells 2014;32:1059-1066
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available